We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
-$2.73M
Cap. Flow %
-2.16%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 42.49%
2 Miscellaneous 37.27%
3 Consumer Staples 5.72%
4 Consumer Discretionary 5.23%
5 Technology 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWAV
351
PUT
DELISTED
The WhiteWave Foods Company
WWAV
$2K ﹤0.01%
30,900
AVXL icon
352
CALL
Anavex Life Sciences
AVXL
$265M
$1K ﹤0.01%
+10,000
New +$42.1K
CCEP icon
353
PUT
Coca-Cola Europacific Partners
CCEP
$46.7B
$1K ﹤0.01%
400
CHTR icon
354
PUT
Charter Communications
CHTR
$18.1B
$1K ﹤0.01%
1,324
COST icon
355
CALL
Costco
COST
$406B
$1K ﹤0.01%
+12,500
New +$2.02M
HAIN icon
356
PUT
Hain Celestial
HAIN
$67.5M
$1K ﹤0.01%
+100
New +$4.38K
LULU icon
357
CALL
lululemon athletica
LULU
$11.1B
$1K ﹤0.01%
30,500
+6,500
+27% +$480K
NKE icon
358
CALL
Nike
NKE
$57B
$1K ﹤0.01%
+5,000
New +$282K
RDUS
359
CALL
DELISTED
Radius Health, Inc.
RDUS
$1K ﹤0.01%
+1,500
New +$76.2K
KITE
360
CALL
DELISTED
Kite Pharma, Inc.
KITE
$1K ﹤0.01%
+2,900
New +$162K
AEGR
361
CALL
DELISTED
Aegerion Pharmaceuticals
AEGR
$1K ﹤0.01%
36,000
CYNA
362
PUT
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$1K ﹤0.01%
+20,000
New +$494K
LXK
363
PUT
DELISTED
Lexmark Intl Inc
LXK
$1K ﹤0.01%
+31,800
New +$1.16M
AAL icon
364
CALL
American Airlines Group
AAL
$8.69B
-55,000
Closed -$135K
AAL icon
365
PUT
American Airlines Group
AAL
$8.69B
-30,000
Closed -$2K
ACN icon
366
Accenture
ACN
$114B
-5,100
Closed -$581K
ADBE icon
367
Adobe
ADBE
$106B
-3,882
Closed -$390K
AKBA icon
368
PUT
Akebia Therapeutics
AKBA
$270M
-45,000
Closed -$16K
AMAT icon
369
CALL
Applied Materials
AMAT
$361B
-47,000
Closed -$102K
AMAT icon
370
PUT
Applied Materials
AMAT
$361B
-27,500
Closed -$19K
AMGN icon
371
CALL
Amgen
AMGN
$236B
-55,000
Closed -$157K
AMGN icon
372
PUT
Amgen
AMGN
$236B
-55,000
Closed -$328K
ARCT icon
373
Arcturus Therapeutics
ARCT
$450M
$0 ﹤0.01%
+2
New +$65
ARWR icon
374
Arrowhead Research
ARWR
$12.2B
-3,039
Closed -$19.7K
ASML icon
375
ASML
ASML
$659B
-334
Closed -$35.4K

Similar funds

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options's Q3 2016 filing shows 153 new, 113 increased, 67 reduced and 127 closed positions. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M. The largest sale was MEDIVATION, INC., an estimated $7.18M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.